AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2011
Mar 21, 2011
34519_dirs_2011-03-21_7fb01289-4e6f-4126-a909-67783fda21e1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2011-03-17
Reporting Person: Tomsche David Scott (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-03-17 | Common Stock, par value $0.10 per share | P | 2000 | $3.44 | Acquired | 32273 | Direct |
| 2011-03-17 | Common Stock, par value $0.10 per share | P | 800 | $3.50 | Acquired | 33073 | Direct |
| 2011-03-17 | Common Stock, par value $0.10 per share | P | 400 | $3.51 | Acquired | 33473 | Direct |
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23